Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of Calgary
$120,000.00
Quantification of Uremic Toxins and Mechanistic Insights into Potential Targeted Treatments for Cardiac Dysfunction in Pediatric Chronic Kidney Disease.
FY 2025-26
Summary
Children with kidney disease have a 10-30 times higher risk of death, with heart complications being the leading cause. When the kidneys do not work properly, harmful toxins can build up in the blood and damage the heart, leading to a condition called cardiorenal syndrome. Though the causes of cardiorenal syndrome differ between children and adults, most research focuses on adults. Further, there is no clear test to detect cardiorenal syndrome in children, delaying diagnosis and lifesaving treatment. Children who need dialysis (a machine that does the work of the kidneys) live 40-50 years less than the general population. Even after a kidney transplant, their lifespan is still 20-25 years shorter. My research aims to measure toxin levels in children, understand how these toxins damage the heart, and test potential treatments.
We do not fully understand which toxins and how much of each build up in children, highlighting a critical and targetable gap in this field. To bridge this gap, I measured levels of four toxins harmful to the heart in blood samples from children with kidney disease. I found that levels of two toxins were much higher in children with cardiorenal syndrome than in those without and that toxin levels returned to normal once their heart disease was treated.
To understand how these toxins affect the heart, I grow human stem cells and transform them into beating heart cells. I expose these cells to toxins and study how they affect heartbeat, contraction, cell damage and stress - indicators of heart health. Then, I will study how these toxins interact with molecules on the surface of heart cells, causing them to become stressed or die. Finally, I will test the ability of two common diabetic drugs to reduce toxic effects and serve as potential future treatments. By understanding which toxins damage a child's kidneys, we can tailor treatments to better reduce toxin accumulation and prevent their specific actions, helping affected children live longer.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
559828
Name
Dalpathadu Heshini A
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Quantification of Uremic Toxins and Mechanistic Insights into Potential Targeted Treatments for Cardiac Dysfunction in Pediatric Chronic Kidney Disease.
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Cardiorenal Syndrome; Cardiotoxicity; Cardiovascular Disease; Chronic Kidney Disease; Disease Mechanism; Induced Pluripotent Stem Cells; Pediatric; Precision Medicine; Targeted Therapeutic; Uremic Toxins
Abstract
Children with kidney disease have a 10-30 times higher risk of death, with heart complications being the leading cause. When the kidneys do not work properly, harmful toxins can build up in the blood and damage the heart, leading to a condition called cardiorenal syndrome. Though the causes of cardiorenal syndrome differ between children and adults, most research focuses on adults. Further, there is no clear test to detect cardiorenal syndrome in children, delaying diagnosis and lifesaving treatment. Children who need dialysis (a machine that does the work of the kidneys) live 40-50 years less than the general population. Even after a kidney transplant, their lifespan is still 20-25 years shorter. My research aims to measure toxin levels in children, understand how these toxins damage the heart, and test potential treatments.
We do not fully understand which toxins and how much of each build up in children, highlighting a critical and targetable gap in this field. To bridge this gap, I measured levels of four toxins harmful to the heart in blood samples from children with kidney disease. I found that levels of two toxins were much higher in children with cardiorenal syndrome than in those without and that toxin levels returned to normal once their heart disease was treated.
To understand how these toxins affect the heart, I grow human stem cells and transform them into beating heart cells. I expose these cells to toxins and study how they affect heartbeat, contraction, cell damage and stress - indicators of heart health. Then, I will study how these toxins interact with molecules on the surface of heart cells, causing them to become stressed or die. Finally, I will test the ability of two common diabetic drugs to reduce toxic effects and serve as potential future treatments. By understanding which toxins damage a child's kidneys, we can tailor treatments to better reduce toxin accumulation and prevent their specific actions, helping affected children live longer.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dalpathadu, Heshini A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~